glp-1 medications common side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 medications may help some

To participate in a fast-growing but competitive and complicated market, GLP-1 originators will need to adopt a differentiated patient- and customer-centric strategy leveraging both internal and external resources to optimize product positioning, building brand equity, integrating software and device solutions beyond the drug itself, and exploring innovative channels

For maintenance therapy without neurological involvement, 1 mg is given every 3 months

Routing, delivery estimates, import requirements, and customs processing depend on destination and carrier conditions

In this article, well look at the promise and peril of using these glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to treat metabolic side effects and explore other potential uses for these medications in psychiatry

doi: 10.1210/endocr/bqaa102